Johansson Cecilia, Graham Sheila V, Dornan Edward S, Morgan Iain M
Institute of Comparative Medicine, University of Glasgow Faculty of Veterinary Medicine, Glasgow, G61 1QH, UK.
Virology. 2009 Nov 25;394(2):194-9. doi: 10.1016/j.virol.2009.08.046. Epub 2009 Sep 24.
The human papillomavirus 16 E2 protein regulates transcription from, and replication of, the viral genome and is also required for segregation of the viral genome via interaction with mitotic bodies. To regulate DNA replication E2 interacts with sequences around the origin of replication and recruits the viral helicase E1 via a protein-protein interaction, which then initiates viral genome replication. The replication role of E2 must originally function in a host cell S phase. In this report, we demonstrate that E2 is stabilised in the S phase of the cell cycle and that this stabilisation is accompanied by an increase in phosphorylation of the protein. This increased phosphorylation and stability are likely required for optimum viral DNA replication and therefore identification of the enzymes involved in regulating these properties of E2 will provide targets for therapeutic intervention in the viral life cycle. Preliminary studies have identified E2 as a Cdk2 substrate demonstrating this enzyme as a candidate kinase for mediating the in vivo phosphorylation of HPV16 E2.
人乳头瘤病毒16型E2蛋白可调节病毒基因组的转录和复制,并且通过与有丝分裂小体相互作用实现病毒基因组的分离也需要该蛋白。为调节DNA复制,E2与复制起点周围的序列相互作用,并通过蛋白质-蛋白质相互作用招募病毒解旋酶E1,随后E1启动病毒基因组复制。E2的复制功能最初必定在宿主细胞S期发挥作用。在本报告中,我们证明E2在细胞周期的S期被稳定化,并且这种稳定化伴随着该蛋白磷酸化作用的增强。这种增强的磷酸化作用和稳定性可能是病毒DNA最佳复制所必需的,因此,鉴定参与调节E2这些特性的酶将为病毒生命周期的治疗干预提供靶点。初步研究已确定E2为细胞周期蛋白依赖性激酶2(Cdk2)的底物,表明该酶是介导人乳头瘤病毒16型E2体内磷酸化作用的候选激酶。